Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

NOUVELLE PHARMACIE CENTRALE : revenue, balance sheet and financial ratios

NOUVELLE PHARMACIE CENTRALE is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in WITTENHEIM (68270), this company of category PME shows in 2023 a net income negative of -10 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NOUVELLE PHARMACIE CENTRALE (SIREN 529648800)
Indicator 2023 2022 2017 2016
Revenue N/C N/C N/C N/C
Net income -9 744 € 107 537 € 102 675 € 65 219 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2023, NOUVELLE PHARMACIE CENTRALE records a net loss of 10 k€. This deficit will reduce equity on the balance sheet.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-9 744 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

23.347%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

64.244%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

34.6%

Solvency indicators evolution
NOUVELLE PHARMACIE CENTRALE

Sector positioning

Debt ratio
23.35 2023
2017
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -16 pts over 3 years

In 2023, the debt ratio of NOUVELLE PHARMACIE CENTRALE (23.35) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
64.24% 2023
2017
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good +19 pts over 3 years

In 2023, the financial autonomy of NOUVELLE PHARMACIE CENTRALE (64.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 219.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

219.499

Liquidity indicators evolution
NOUVELLE PHARMACIE CENTRALE

Sector positioning

Liquidity ratio
219.5 2023
2017
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good

In 2023, the liquidity ratio of NOUVELLE PHARMACIE CENTRALE (219.50) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of NOUVELLE PHARMACIE CENTRALE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare NOUVELLE PHARMACIE CENTRALE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about NOUVELLE PHARMACIE CENTRALE

What is the revenue of NOUVELLE PHARMACIE CENTRALE ?

The revenue of NOUVELLE PHARMACIE CENTRALE is not publicly disclosed (confidential accounts filed with INPI).

Is NOUVELLE PHARMACIE CENTRALE profitable?

NOUVELLE PHARMACIE CENTRALE recorded a net loss in 2023.

Where is the headquarters of NOUVELLE PHARMACIE CENTRALE ?

The headquarters of NOUVELLE PHARMACIE CENTRALE is located in WITTENHEIM (68270), in the department Haut-Rhin.

Where to find the tax return of NOUVELLE PHARMACIE CENTRALE ?

The tax return of NOUVELLE PHARMACIE CENTRALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NOUVELLE PHARMACIE CENTRALE operate?

NOUVELLE PHARMACIE CENTRALE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.